Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells.
about
Human scavenger receptor class B type II (SR-BII) and cellular cholesterol effluxThe APOL1 gene and allograft survival after kidney transplantationLoss of Reelin protects against atherosclerosis by reducing leukocyte-endothelial cell adhesion and lesion macrophage accumulationApolipoprotein E Gene Variants and Risk of Coronary Heart Disease: A Meta-AnalysisApolipoprotein E (apoE) isoforms differentially induce nitric oxide production in endothelial cellsInhibition of the canonical Wnt signaling pathway by apolipoprotein E4 in PC12 cellsAltered gene expression in early atherosclerosis is blocked by low level apolipoprotein EAnti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH(2)Apolipoprotein E gene polymorphism and dyslipidaemia in adult Asian Indians: A population based study from Calcutta, IndiaapoE3[K146N/R147W] acts as a dominant negative apoE form that prevents remnant clearance and inhibits the biogenesis of HDL.Apolipoprotein E receptor-2 deficiency enhances macrophage susceptibility to lipid accumulation and cell death to augment atherosclerotic plaque progression and necrosis.Apolipoprotein E-related all-cause mortality in hospitalized elderly patients.Pulmonary hypertension and metabolic syndrome: Possible connection, PPARγ and Caveolin-1Apolipoprotein E inhibits toll-like receptor (TLR)-3- and TLR-4-mediated macrophage activation through distinct mechanisms.A novel mechanism of γ/δ T-lymphocyte and endothelial activation by shear stress: the role of ecto-ATP synthase β chainApolipoprotein E polymorphism and atherosclerosis.ApoE suppresses atherosclerosis by reducing lipid accumulation in circulating monocytes and the expression of inflammatory molecules on monocytes and vascular endotheliumSubsets of SNPs define rare genotype classes that predict ischemic heart disease.Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein.Apolipoprotein E Receptor 2 Mediates Activated Protein C-Induced Endothelial Akt Activation and Endothelial Barrier StabilizationOxidative stress regulates adipocyte apolipoprotein e and suppresses its expression in obesity.Apolipoprotein E enhances endothelial-NO production by modulating caveolin 1 interaction with endothelial NO synthase.ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.Cortical injury increases cholesterol 24S hydroxylase (Cyp46) levels in the rat brain.Apolipoprotein E mimetics and cholesterol-lowering properties.Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression.Protective effect of apolipoprotein E2 on coronary artery disease in African Americans is mediated through lipoprotein cholesterol.Cholesterol accumulation inhibits ER to Golgi transport and protein secretion: studies of apolipoprotein E and VSVGt.Apolipoprotein E and Atherosclerosis: From Lipoprotein Metabolism to MicroRNA Control of Inflammation.
P2860
Q24298168-04CEC06A-6D55-4E26-B101-C5C6D693215FQ24606604-E7090973-D34E-4BEF-9646-A63A612B6F60Q27329447-AFB6F355-7DD6-451E-BFCE-C9BF8EC48C5CQ28073311-B9478B08-6F4F-4A32-ACD2-35DD1AB429B1Q28189379-43B8811F-78BC-4995-8FCA-6A272EBF000AQ28771380-B2895239-0286-435B-818A-53351D6FF46CQ33344456-0CBC7975-B814-4A99-AE93-033AEF3B4A3BQ33618352-E559A099-14FC-48A5-95E1-FDB42277D107Q33735872-E09731A3-1DC8-4EA9-AF5D-FB3997478867Q33825134-5B7490F9-C5A7-4051-BF26-507C209C126BQ34016939-571D7BC6-1B11-4133-9E7B-CDC420E1950FQ34080448-6D911F7D-6E58-49EC-A863-B6138B668CA2Q34178976-631F8886-FFFA-45D4-90A6-8888F21ACF57Q34630303-756A6E09-C274-4C64-874B-59C47DA245E5Q34645908-8BEB4226-8207-4EFE-97DE-F001F0D133AFQ35068761-FC6725DA-8594-4218-92E2-DAB0011CED87Q35744441-041E6A85-887A-4B8E-835F-FFB580392CB0Q35748369-F051DF19-5A14-45EB-A84E-311FE7710344Q35974993-BB4016A2-14D8-4C2C-A8A4-CE22B6BBCB1BQ36753466-A51C4E35-B11D-4C8A-8D19-22215796C0ABQ36943723-2A7B2858-6AEF-431D-8F6B-5E3BDF9C742BQ37088486-16793512-D0C6-4163-99E8-347D394DF137Q37186078-86435752-0EE9-4045-86E7-B7BB0238230CQ37349958-7A462564-7096-4FAB-8D86-FF90FE8DD4F2Q37965590-D1CA7106-68B4-4240-B5E6-3F9E18EF2EBAQ40148295-C0921D31-1884-4C67-A979-E7C3334B2153Q46948459-9E7AF85E-5A14-44D1-B905-4E4D92D21D9BQ50494313-1E0E0670-88A6-4CCE-9D21-A5780D3F8D77Q55416365-A8D9EC68-AAB3-4DC6-9E33-2A5D594FD352
P2860
Cell-derived apolipoprotein E (ApoE) particles inhibit vascular cell adhesion molecule-1 (VCAM-1) expression in human endothelial cells.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Cell-derived apolipoprotein E ...... on in human endothelial cells.
@en
Cell-derived apolipoprotein E
@nl
type
label
Cell-derived apolipoprotein E ...... on in human endothelial cells.
@en
Cell-derived apolipoprotein E
@nl
prefLabel
Cell-derived apolipoprotein E ...... on in human endothelial cells.
@en
Cell-derived apolipoprotein E
@nl
P2093
P2860
P356
P1476
Cell-derived apolipoprotein E ...... on in human endothelial cells.
@en
P2093
Athanasopoulos T
Riddell DR
Stannard AK
Tagalakis AD
von Eckardstein A
P2860
P304
46011-46016
P356
10.1074/JBC.M104812200
P407
P577
2001-10-05T00:00:00Z